Keel Point LLC Trims Stock Position in Danaher Corporation $DHR

Keel Point LLC lessened its stake in Danaher Corporation (NYSE:DHRFree Report) by 88.0% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,405 shares of the conglomerate’s stock after selling 17,558 shares during the period. Keel Point LLC’s holdings in Danaher were worth $456,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in DHR. Main Street Group LTD purchased a new stake in shares of Danaher in the 1st quarter valued at about $25,000. JPL Wealth Management LLC acquired a new stake in shares of Danaher in the 3rd quarter valued at about $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the 4th quarter worth approximately $26,000. WFA of San Diego LLC acquired a new position in Danaher during the second quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter worth approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.4%

NYSE DHR opened at $197.78 on Tuesday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $139.03 billion, a P/E ratio of 35.13, a P/E/G ratio of 2.43 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a 50-day moving average price of $188.87 and a 200 day moving average price of $195.08.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the previous year, the company earned $0.77 EPS. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. Equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Analysts Set New Price Targets

DHR has been the subject of several research analyst reports. Evercore reissued an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Guggenheim reduced their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Get Our Latest Analysis on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.